By improving insulin sensitivity, these medications combat insulin resistance, helping to stabilize blood sugar levels and reduce fatigue and cravings
If you have severe kidney or liver disease, you need medical advice before starting
There is no TGA-registered BPC-157 product for therapeutic use in Australia, and as of June 2024 BPC-157 is a Schedule 4 (prescription-only) substance, meaning any legal supply must come through a doctors prescription via a compounding pharmacy
So, it's going through a transporter called the Mfsd2a transporter
I have only seen about 8 patients on both GLP-1 agonists and stimulants as of early April 2026, but the slower gastric emptying results in immediate release stimulants lasting longer and working more like an extended-release version, but with slightly different properties than existing extended-release formulations